Zimmer Biomet Holdings (ZBH) said Monday it has completed its acquisition of medical device company Paragon 28.

Each Paragon 28 share was converted into the right to get $13 in cash and a non-tradeable contingent value right entitling holders to receive cash of up to $1 per share if certain revenue milestones are met, Zimmer Biomet said.

The company said shares of Paragon 28, which is now its wholly owned unit, ceased trading on the New York Stock Exchange before the market opened on Monday and will be delisted.

Price: 94.39, Change: -3.54, Percent Change: -3.61